Jaswinder K Ghuman

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi Behavioral training for pill-swallowing difficulties in young children with autistic disorder
    Jaswinder K Ghuman
    Johns Hopkins University Kennedy Krieger Institute, Baltimore, Maryland, USA
    J Child Adolesc Psychopharmacol 14:601-11. 2004
  2. ncbi Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?
    Jaswinder K Ghuman
    Child and Adolescent Psychiatry, University of Arizona, Room AHSC 7304, 1501 N Campbell Ave, Tucson, AZ, 85724 5002, USA
    Paediatr Drugs 15:1-8. 2013
  3. ncbi The screen for social interaction (SSI): a screening measure for autism spectrum disorders in preschoolers
    Jaswinder K Ghuman
    University of Arizona, Child and Adolescent Psychiatry, 1501 N, Campbell Avenue Tucson, AZ 85724 5002, USA
    Res Dev Disabil 32:2519-29. 2011
  4. ncbi Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders
    Jaswinder K Ghuman
    University of Arizona, Child and Adolescent Psychiatry, Tucson, Arizona 85724 5002, USA
    J Child Adolesc Psychopharmacol 19:329-39. 2009
  5. ncbi Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder
    Jaswinder K Ghuman
    Department of Psychiatry, University of Arizona, Tucson, Arizona 85724 5002, USA
    J Child Adolesc Psychopharmacol 19:155-66. 2009
  6. ncbi Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice
    Jaswinder K Ghuman
    Department of Psychiatry, University of Arizona, Tucson, Arizona 85724 5002, USA
    J Child Adolesc Psychopharmacol 18:413-47. 2008
  7. ncbi Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Jaswinder K Ghuman
    University of Arizona, 1501 N Campbell Avenue, Tucson, AZ 85724, USA
    J Child Adolesc Psychopharmacol 17:563-80. 2007
  8. ncbi Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kristina K Hardy
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:621-34. 2007
  9. ncbi Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Desiree W Murray
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:605-20. 2007
  10. ncbi Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology
    Christopher J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202 4800, USA
    Am J Psychiatry 162:1142-8. 2005

Research Grants

  1. METHYLPHENIDATE STUDY IN YOUNG CHILDREN WITH PDD
    Jaswinder Ghuman; Fiscal Year: 2005

Detail Information

Publications16

  1. ncbi Behavioral training for pill-swallowing difficulties in young children with autistic disorder
    Jaswinder K Ghuman
    Johns Hopkins University Kennedy Krieger Institute, Baltimore, Maryland, USA
    J Child Adolesc Psychopharmacol 14:601-11. 2004
    ..This pilot study describes our experience in teaching pill-swallowing skills to 4 children with AD who also had comorbid symptoms associated with ADHD...
  2. ncbi Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?
    Jaswinder K Ghuman
    Child and Adolescent Psychiatry, University of Arizona, Room AHSC 7304, 1501 N Campbell Ave, Tucson, AZ, 85724 5002, USA
    Paediatr Drugs 15:1-8. 2013
    ..Further research is needed to identify predictors and moderators of response to guide individualized/optimal treatment options for ADHD in preschoolers...
  3. ncbi The screen for social interaction (SSI): a screening measure for autism spectrum disorders in preschoolers
    Jaswinder K Ghuman
    University of Arizona, Child and Adolescent Psychiatry, 1501 N, Campbell Avenue Tucson, AZ 85724 5002, USA
    Res Dev Disabil 32:2519-29. 2011
    ..87 and 0.71, respectively for the SSI-Y and 0.81 and 0.70, respectively for the SSI-O. Scoring recommendations were made based on the ROC results...
  4. ncbi Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders
    Jaswinder K Ghuman
    University of Arizona, Child and Adolescent Psychiatry, Tucson, Arizona 85724 5002, USA
    J Child Adolesc Psychopharmacol 19:329-39. 2009
    ....
  5. ncbi Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder
    Jaswinder K Ghuman
    Department of Psychiatry, University of Arizona, Tucson, Arizona 85724 5002, USA
    J Child Adolesc Psychopharmacol 19:155-66. 2009
    ..The aim of this study was to report preliminary data regarding effectiveness and tolerability of atomoxetine in 3- to 5-year-old preschool children with attention-deficit/hyperactivity disorder (ADHD)...
  6. ncbi Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice
    Jaswinder K Ghuman
    Department of Psychiatry, University of Arizona, Tucson, Arizona 85724 5002, USA
    J Child Adolesc Psychopharmacol 18:413-47. 2008
    ..This article reviews rational approaches to treating attention-deficit/hyperactivity disorder (ADHD) in preschool children, including pharmacological and nonpharmacological treatments. Implications for clinical practice are discussed...
  7. ncbi Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Jaswinder K Ghuman
    University of Arizona, 1501 N Campbell Avenue, Tucson, AZ 85724, USA
    J Child Adolesc Psychopharmacol 17:563-80. 2007
    ..The aim of this study was to examine whether demographic or pretreatment clinical and social characteristics influenced the response to methylphenidate (MPH) in the Preschoolers with ADHD Treatment Study (PATS)...
  8. ncbi Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kristina K Hardy
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:621-34. 2007
    ....
  9. ncbi Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Desiree W Murray
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:605-20. 2007
    ..To assess parent-teacher concordance on ratings of DSM-IV symptoms of attention-deficit/hyperactivity disorder (ADHD) in a sample of preschool children referred for an ADHD treatment study...
  10. ncbi Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology
    Christopher J McDougle
    Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202 4800, USA
    Am J Psychiatry 162:1142-8. 2005
    ..The authors report on whether risperidone improves the core symptoms of autism, social and communication impairment and repetitive and stereotyped behavior...
  11. ncbi Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kelly Posner
    New York State Psychiatric Institute Columbia University, 1041 Riverside Drive, New York, NY 10032, USA
    J Child Adolesc Psychopharmacol 17:547-62. 2007
    ..The diagnosis and evaluation process will also be described...
  12. ncbi Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Benedetto Vitiello
    Child and Adolescent Treatment and Preventive Intervention Research Branch, National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD 20892, USA
    J Child Adolesc Psychopharmacol 17:593-604. 2007
    ..The aim of this study was to examine immediate-release methylphenidate effectiveness during the 10-month open-label continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment Study (PATS)...
  13. ncbi Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Howard B Abikoff
    New York University Child Study Center, 215 Lexington Avenue, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 17:581-92. 2007
    ....
  14. ncbi Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    James M Swanson
    Child Development Center, University of California Irvine, 19722 MacArthur Boulevard, Irvine, CA 92612, USA
    J Child Adolesc Psychopharmacol 17:635-46. 2007
    ....
  15. ncbi Validity of the autism diagnostic interview-revised
    Luc Lecavalier
    Nisonger Center, The Ohio State University, Columbus, USA
    Am J Ment Retard 111:199-215. 2006
    ..They indicated some similarities between constructs, but also that the ADI-R measures autism in a unique fashion...
  16. ncbi Acute and long-term safety and tolerability of risperidone in children with autism
    Michael G Aman
    The Nisonger Center, Ohio State University, Columbus, Ohio 43210 1296, USA
    J Child Adolesc Psychopharmacol 15:869-84. 2005
    ..Most AEs were mild to moderate and failed to interfere with therapeutic changes; there were no unanticipated AEs. The side effects of most concern were somnolence and weight gain...

Research Grants1

  1. METHYLPHENIDATE STUDY IN YOUNG CHILDREN WITH PDD
    Jaswinder Ghuman; Fiscal Year: 2005
    ..The proposed training program will allow the candidate to acquire sufficient expertise to carry out future treatment intervention studies in a very specialized area. ..